Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2009

01-04-2009 | Original Article

Fasting Exacerbates and Feeding Diminishes LPS-Induced Liver Injury in the Rat

Authors: Sasha D. Adams, Benjamin A. Delano, Kenneth S. Helmer, David W. Mercer

Published in: Digestive Diseases and Sciences | Issue 4/2009

Login to get access

Abstract

Introduction Enteral nutrition improves clinical outcomes. The effects of feeding on LPS induced liver injury are unknown. We hypothesized that feeding would attenuate liver injury from LPS. Methods Fasted or fed rats were given LPS (20 mg/kg ip) or saline for 5 h and sacrificed. Serum aminotransferases and cytokines (immunoassay) were measured. Oxidative stress protein (iNOS, COX2, and HO1) assessments (Western immunoblot) were also obtained. Results In fasted rats, LPS significantly increased serum aminotransferase levels, enhanced hepatic COX2, iNOS, and HO1 immunoreactivity, and increased serum cytokine levels when compared to controls. While feeding diminished liver enzymes, attenuated expression of COX2 and iNOS, and blunted production of pro-inflammatory cytokines, it did not modulate LPS-induced expression of the anti-inflammatory markers HO1 and IL-10. Conclusion These data suggest that feeding decreases liver injury by attenuating expression of pro-inflammatory mediators while maintaining expression of anti-inflammatory mediators, both systemically and locally.
Literature
8.
go back to reference Moore FA, Weisbrodt NW (2003) Gut dysfunction and intolerance to enteral nutrition in critically ill patients. Nestle Nutr Workshop Ser Clin Perform Programme 8:149–170PubMedCrossRef Moore FA, Weisbrodt NW (2003) Gut dysfunction and intolerance to enteral nutrition in critically ill patients. Nestle Nutr Workshop Ser Clin Perform Programme 8:149–170PubMedCrossRef
9.
go back to reference McClave SA, DeMeo MT, DeLegge MH, DiSario JA, Heyland DK, Maloney JP et al (2002) North American summit on aspiration in the critically ill patient: consensus statement. J Parenter Enter Nutr 26(Suppl 6):S80–S85 McClave SA, DeMeo MT, DeLegge MH, DiSario JA, Heyland DK, Maloney JP et al (2002) North American summit on aspiration in the critically ill patient: consensus statement. J Parenter Enter Nutr 26(Suppl 6):S80–S85
12.
go back to reference Minard G, Kudsk KA (1994) Effect of route of feeding on the incidence of septic complications in critically ill patients. Semin Respir Infect 9(4):228–231PubMed Minard G, Kudsk KA (1994) Effect of route of feeding on the incidence of septic complications in critically ill patients. Semin Respir Infect 9(4):228–231PubMed
21.
go back to reference Spitzer JA, Zheng M, Kolls JK, Vande Stouwe C, Spitzer JJ (2002) Ethanol and LPS modulate NF-kappaB activation, inducible NO synthase and COX-2 gene expression in rat liver cells in vivo. Front Biosci 7:a99–a108. doi:10.2741/spitzer PubMedCrossRef Spitzer JA, Zheng M, Kolls JK, Vande Stouwe C, Spitzer JJ (2002) Ethanol and LPS modulate NF-kappaB activation, inducible NO synthase and COX-2 gene expression in rat liver cells in vivo. Front Biosci 7:a99–a108. doi:10.​2741/​spitzer PubMedCrossRef
22.
go back to reference Morse D, Choi AM (2002) Heme oxygenase-1: the “emerging molecule” has arrived. Am J Respir Cell Mol Biol 27(1):8–16PubMed Morse D, Choi AM (2002) Heme oxygenase-1: the “emerging molecule” has arrived. Am J Respir Cell Mol Biol 27(1):8–16PubMed
23.
go back to reference Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK et al (1999) Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1(3):152–157. doi:10.1038/11072 PubMedCrossRef Ferris CD, Jaffrey SR, Sawa A, Takahashi M, Brady SD, Barrow RK et al (1999) Haem oxygenase-1 prevents cell death by regulating cellular iron. Nat Cell Biol 1(3):152–157. doi:10.​1038/​11072 PubMedCrossRef
28.
go back to reference Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A (1999) Change in the ratio of Interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27(7):1262–1264. doi:10.1097/00003246-199907000-00005 PubMedCrossRef Taniguchi T, Koido Y, Aiboshi J, Yamashita T, Suzaki S, Kurokawa A (1999) Change in the ratio of Interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 27(7):1262–1264. doi:10.​1097/​00003246-199907000-00005 PubMedCrossRef
32.
go back to reference Mercer DW, Castaneda AA, Denning JW, Chang L, Russell DH (1998) Effects of endotoxin on gastric injury from luminal irritants in rats: potential roles for nitric oxide. Am J Physiol 275(3 Pt 1):G449–G459PubMed Mercer DW, Castaneda AA, Denning JW, Chang L, Russell DH (1998) Effects of endotoxin on gastric injury from luminal irritants in rats: potential roles for nitric oxide. Am J Physiol 275(3 Pt 1):G449–G459PubMed
33.
go back to reference Ahmad N, Chen LC, Gordon MA, Laskin JD, Laskin DL (2002) Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J Leukoc Biol 71:1005–1011PubMed Ahmad N, Chen LC, Gordon MA, Laskin JD, Laskin DL (2002) Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J Leukoc Biol 71:1005–1011PubMed
37.
go back to reference Mercer DW, Klemm K, Cross JM, Smith GS, Cashman M, Miller TA (1996) Cholecystokinin-induced protection against gastric injury is independent of endogenous somatostatin. Am J Physiol 271:G692–G700PubMed Mercer DW, Klemm K, Cross JM, Smith GS, Cashman M, Miller TA (1996) Cholecystokinin-induced protection against gastric injury is independent of endogenous somatostatin. Am J Physiol 271:G692–G700PubMed
38.
go back to reference Mercer DW, Cross JM, Smith GA, Miller TA (1997) Protective action of gastrin-17 against alcohol induced gastric injury in the rat: role in mucosal defense. Am J Physiol 273:G365–G373PubMed Mercer DW, Cross JM, Smith GA, Miller TA (1997) Protective action of gastrin-17 against alcohol induced gastric injury in the rat: role in mucosal defense. Am J Physiol 273:G365–G373PubMed
42.
go back to reference Pappagallo M (2001) Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 182(5A Suppl):11S–18SPubMedCrossRef Pappagallo M (2001) Incidence, prevalence, and management of opioid bowel dysfunction. Am J Surg 182(5A Suppl):11S–18SPubMedCrossRef
43.
go back to reference Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB et al (1992) Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 216(2):172–183. doi:10.1097/00000658-199208000-00008 PubMedCrossRef Moore FA, Feliciano DV, Andrassy RJ, McArdle AH, Booth FV, Morgenstein-Wagner TB et al (1992) Early enteral feeding, compared with parenteral, reduces postoperative septic complications. The results of a meta-analysis. Ann Surg 216(2):172–183. doi:10.​1097/​00000658-199208000-00008 PubMedCrossRef
44.
go back to reference Deitch EA (1993) Nutrition and the gut mucosal barrier. Curr Opin Gen Surg. 1993:85–91 Deitch EA (1993) Nutrition and the gut mucosal barrier. Curr Opin Gen Surg. 1993:85–91
45.
go back to reference Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA (2001) Post-injury multiple organ failure: the role of the gut. Shock 15(1):1–10PubMedCrossRef Hassoun HT, Kone BC, Mercer DW, Moody FG, Weisbrodt NW, Moore FA (2001) Post-injury multiple organ failure: the role of the gut. Shock 15(1):1–10PubMedCrossRef
Metadata
Title
Fasting Exacerbates and Feeding Diminishes LPS-Induced Liver Injury in the Rat
Authors
Sasha D. Adams
Benjamin A. Delano
Kenneth S. Helmer
David W. Mercer
Publication date
01-04-2009
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2009
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-008-0425-5

Other articles of this Issue 4/2009

Digestive Diseases and Sciences 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.